Equity Brief · Healthcare2026-05-20
MDT·Healthcare

Medtronic PLC

I · Analiza AI

Pe scurt

Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.

Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].

Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.

Pe scurt AI analysisÎncredere 7/10

Scor Sentinellis

5.3/10

Moderate concerns

Capitalizare bursieră

$100.9B

Venituri (12 luni)

$33.5B

II · Știri recente

Ce a mișcat prețul

6 stories · ranked by relevance

  • macro2026-05-18

    Mental Health Matters at Medtronic. Explore Our Employee Benefits

    Yahoo Finance

  • macro2026-05-19

    Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks

    Simply Wall St

  • macro2026-05-18

    Medtronic (MDT) Advances While Market Declines: Some Information for Investors

    Yahoo Finance

  • macro2026-05-18

    Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

    Yahoo Finance

  • macro2026-05-17

    A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years

    Yahoo Finance

  • macro2026-05-14

    Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?

    Yahoo Finance

Premium · gratuit cu orice cont

Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]

1 din 5 riscuri din acest raport

Riscuri

5

Oportunități

6

Semnale de alarmă

3

Conducere

10

Încă 23 de constatări în raportul complet — gratuit cu orice cont.

Deblochează analiza completă Medtronic PLC

Fă-ți un cont gratuit ca să vezi raportul complet generat de AI, cu surse citate în text.

  • 5 riscuri, 6 oportunități și 3 semnale de alarmă — fiecare cu sursa lui
  • Peste 100 de indicatori financiari, cu grafice și comparații
  • Rezumate complete ale știrilor, cu linkuri către surse
  • Echipa de conducere și remunerația
  • Export PDF pentru citit offline
Deblochează 14 constatări3 rapoarte gratuite · fără card

III · Companii similare

Ai putea citi și

Same sector · Healthcare or comparable health

Vrei compania asta pe lista ta?

Read three companies free. Fără card.

Primești 3 rapoarte gratuite
Medtronic PLC (MDT) Analiză financiară în limbaj simplu — Sentinellis